Note: Ingredients listed on restricted chemical lists
EC/CAS
201-070-7/77-93-0
Name of the chemical
citric acid, triethyl ester
Concentration
*
EC/CAS
231-545-4/7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
*
EC/CAS
238-877-9/14807-96-6
Name of the chemical
Talc
Concentration
*
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
*
EC/CAS
232-679-6/9005-25-8
Name of the chemical
Starch
Concentration
*
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
*
General Information
Revision date
2006-12-15
Product name
ARTHROTEC(R)
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: White tablet
Signal word
WARNING
Hazard statements
Causes eye irritation. Causes skin irritation. Harmful if swallowed. May cause damage to: blood and blood forming organs, liver, heart, gastrointestinal system through prolonged or repeated exposure. Suspected of damaging the unborn child. May cause allergic reaction in aspirin-sensitive individuals
Additional information
Short Term: May cause eye irritation, May cause skin irritation. (based on components) . Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on blood, spleen, reproductive system, gastrointestinal system. Animal studies indicate that this material may cause adverse effects on the the developing fetus. Known Clinical Effects: Clinical use has caused effects on the gastrointestinal system, including abdominal pain, nausea, vomiting, diarrhea, constipation, peptic ulcer, acid reflux, and gastrointestinal bleeding. Clinical use has resulted in liver effects. Symptoms may include jaundice, liver function test abnormalities, and hepatitis. Clinical use has caused effects on the nervous system, including drowsiness, anxiety, dizziness, visual disturbances. Serious allergic reactions, including anaphylaxis, have been reported. Clinical use of this drug has caused decreased red blood cell count (anemia), effects on blood forming organs. Drugs of this class may cause menstrual irregularities, cramps, pain, postmenopausal menstrual bleeding, miscarriage, uterine rupture, bleeding and death. Miscarriages have been seen in pregnant women taking this drug. Clinical use has caused effects on the cardiovascular system, including heart attack (myocardial infarction), stroke. EU Indication of danger: Harmful Toxic to Reproduction: Category 2 EU Hazard Symbols: EU Risk Phrases: R22 - Harmful if swallowed. R61 - May cause harm to the unborn child. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.